| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
125,358 |
110,058 |
$12.11M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
28,196 |
24,958 |
$1.64M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
13,020 |
12,365 |
$839K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
10,992 |
10,500 |
$720K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
10,925 |
10,185 |
$678K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
9,457 |
8,771 |
$584K |
| 87428 |
|
9,351 |
9,057 |
$465K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,536 |
2,299 |
$355K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
2,377 |
2,185 |
$216K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
15,171 |
14,270 |
$201K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
12,974 |
8,204 |
$181K |
| 90670 |
|
7,688 |
7,417 |
$149K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
724 |
698 |
$149K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
5,603 |
5,282 |
$142K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
10,106 |
9,072 |
$142K |
| D1206 |
Topical application of fluoride varnish |
7,205 |
6,684 |
$123K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
12,952 |
11,907 |
$122K |
| 99223 |
Prolong inpt eval add15 m |
700 |
646 |
$121K |
| 90633 |
|
6,434 |
6,149 |
$121K |
| 90698 |
|
6,279 |
6,090 |
$119K |
| 90686 |
|
6,146 |
5,928 |
$116K |
| 90651 |
|
5,506 |
5,256 |
$112K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,626 |
2,473 |
$111K |
| 90680 |
|
5,751 |
5,558 |
$109K |
| 92551 |
|
22,002 |
20,079 |
$107K |
| 99173 |
|
24,027 |
22,096 |
$106K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,241 |
2,078 |
$104K |
| 99233 |
Prolong inpt eval add15 m |
1,090 |
690 |
$101K |
| 90744 |
|
3,997 |
3,839 |
$75K |
| D0145 |
Oral evaluation for a patient under three years of age |
7,270 |
6,678 |
$66K |
| 83655 |
|
4,218 |
4,025 |
$60K |
| 90685 |
|
2,618 |
2,528 |
$48K |
| 99460 |
|
532 |
462 |
$41K |
| 87420 |
|
2,842 |
2,740 |
$39K |
| 94664 |
|
3,724 |
3,459 |
$35K |
| 90621 |
|
1,853 |
1,745 |
$34K |
| 90672 |
|
1,716 |
1,662 |
$33K |
| 90734 |
|
1,697 |
1,579 |
$31K |
| 90619 |
|
1,437 |
1,389 |
$27K |
| 90710 |
|
1,439 |
1,337 |
$26K |
| 74018 |
|
1,528 |
1,444 |
$26K |
| 90677 |
|
1,244 |
1,238 |
$24K |
| 80061 |
Lipid panel |
1,782 |
1,710 |
$24K |
| 90715 |
|
1,197 |
1,138 |
$22K |
| 90461 |
|
439 |
415 |
$22K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,259 |
2,076 |
$21K |
| 90696 |
|
1,149 |
1,060 |
$21K |
| 87634 |
|
439 |
429 |
$20K |
| 90716 |
|
1,041 |
1,003 |
$20K |
| 90707 |
|
947 |
925 |
$18K |
| 90697 |
|
882 |
860 |
$17K |
| 71046 |
Radiologic examination, chest; 2 views |
922 |
823 |
$16K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
607 |
583 |
$16K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,615 |
1,576 |
$16K |
| 0071A |
|
418 |
403 |
$15K |
| 90671 |
|
725 |
724 |
$14K |
| 96127 |
|
4,088 |
3,921 |
$13K |
| 0072A |
|
326 |
321 |
$13K |
| 86235 |
|
664 |
616 |
$11K |
| 90700 |
|
618 |
582 |
$11K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,146 |
1,038 |
$11K |
| 99462 |
|
217 |
130 |
$8K |
| 99177 |
|
450 |
426 |
$8K |
| 81002 |
|
2,574 |
2,365 |
$7K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
145 |
140 |
$7K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
81 |
77 |
$5K |
| 0001A |
|
151 |
126 |
$4K |
| 90648 |
|
221 |
206 |
$4K |
| 0002A |
|
101 |
97 |
$4K |
| 81025 |
|
1,363 |
1,246 |
$4K |
| 0081A |
|
103 |
99 |
$4K |
| 36416 |
|
1,645 |
1,458 |
$4K |
| 90647 |
|
141 |
140 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
244 |
230 |
$3K |
| 90480 |
|
59 |
59 |
$2K |
| 87101 |
|
247 |
226 |
$2K |
| 0003A |
|
28 |
27 |
$1K |
| 82947 |
|
295 |
249 |
$1K |
| 0082A |
|
14 |
14 |
$560.00 |
| 0073A |
|
13 |
12 |
$280.00 |
| 99070 |
|
241 |
215 |
$259.20 |
| 36415 |
Collection of venous blood by venipuncture |
30 |
28 |
$56.00 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
26 |
24 |
$47.54 |
| 97802 |
|
30 |
29 |
$0.00 |
| 91307 |
|
34 |
12 |
$0.00 |
| 71020 |
|
17 |
15 |
$0.00 |